Well-Being and Mental Health: Where Do We Stand After COVID-19 Pandemic?
- PMID: 39693599
- DOI: 10.1097/NMD.0000000000001815
Well-Being and Mental Health: Where Do We Stand After COVID-19 Pandemic?
Abstract
Mental health encompasses the ability to cope with important stresses of life and to realize one's abilities in the community, and the COVID-19 pandemic represented a very stressful event for people with mental illnesses. Our aim was to assess mental well-being in people living with different mental disorders, comparing results obtained in 2016 with those observed after the COVID-19 pandemic. Ninety-six participants were assessed using the Mental Health Continuum Short Form and classified as "flourishing," "moderately mentally healthy," and "languishing." Overall, a significant increase in the prevalence of "flourishing" and "moderately mentally healthy" subjects and a reduction of "languishing" subjects ( p = 0.003) were observed. However, a significant improvement in well-being ( p = 0.005) was observed only in the schizophrenia spectrum disorder group. Moreover, only subjects that never contracted SARS-CoV-2 showed a significant ( p = 0.019) increase in positive well-being states. Lockdowns may have led caregivers to spend more time with the participants, also increasing treatment adherence, resulting in an improvement of overall well-being in several participants.
Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc.
References
-
- Ali K, Iasiello M, van Agteren J, Mavrangelos T, Kyrios M, Fassnacht DB (2022) A cross-sectional investigation of the mental health and wellbeing among individuals who have been negatively impacted by the COVID-19 international border closure in Australia. Global Health . 18:12.
-
- American Psychiatric Association (2000) Diagnostic and statistic manual of mental disorders, fourth edition, revised; DSM-IV-TR . Washington: American Psychiatric Publishing.
-
- Barlati S, Nibbio G, Bianchi F, Gigli EBL, Calzavara-Pinton I, Cerati C, Fiori J, Lisoni J, Deste G, Vita A (2022) Long-acting injectable antipsychotics during the COVID-19 pandemic in schizophrenia: An observational study in a real-world clinical setting. Psychiatry Research . 317:114878.
-
- Barlati S, Nibbio G, Vita A (2021) Schizophrenia during the COVID-19 pandemic. Curr Opin Psychiatry . 34:203–210.
-
- Brown JE, Mezquida G, Fernandez-Egea E (2016) Well-being in clozapine-treated schizophrenia patients: The significance of positive symptoms. Compr Psychiatry . 68:140–146.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous